4.2 Article

ALENDRONATE REDUCES PERIPROSTHETIC BONE LOSS AFTER UNCEMENTED PRIMARY TOTAL HIP ARTHROPLASTY - A 5-YEAR FOLLOW-UP OF 16 PATIENTS

Related references

Note: Only part of the references are listed.
Article Endocrinology & Metabolism

A prospective study of proximal femur bone mass following cemented and uncemented hip arthroplasty

Michael E. Marchetti et al.

JOURNAL OF BONE AND MINERAL RESEARCH (2010)

Article Orthopedics

Does bone quality predict loosening of cemented total hip replacements?

M. Nixon et al.

JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME (2007)

Article Orthopedics

Clinical and radiological outcome of total hip replacement five years after pamidronate therapy - A trial extension

N. Shetty et al.

JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME (2006)

Article Endocrinology & Metabolism

Meta-analysis of the efficacy of alendronate for the prevention of hip fractures in postmenopausal women

SE Papapoulos et al.

OSTEOPOROSIS INTERNATIONAL (2005)

Article Medicine, General & Internal

Ten years' experience with alendronate for osteoporosis in postmenopausal women

HG Bone et al.

NEW ENGLAND JOURNAL OF MEDICINE (2004)

Article Endocrinology & Metabolism

Alendronate reduces periprosthetic bone loss after uncemented primary total hip arthroplasty:: A prospective randomized study

PK Venesmaa et al.

JOURNAL OF BONE AND MINERAL RESEARCH (2001)